%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Nynke M. Kannegieter, Dennis A. Hesselink, Marjolein Dieterich, Gretchen N. de Graav, Rens Kraaijeveld, Carla C. Baan
Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref004)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref010)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref011)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref012)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref011)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref013)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref014)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.g001)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.g001)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref011)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref015)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref019)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref020)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref021)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref024)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref025)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref026)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref020)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref027)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0201113.ref028)>>
endobj
37 0 obj
<>/Border[0 0 0]/A 38 0 R>>
endobj
38 0 obj
<>
endobj
14 0 obj
[39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R]
endobj
39 0 obj
<>stream
q
0.83 0.64 0.02 0 k
312.6047 674.9858 m
317.3669 674.9858 l
h
f*
322.526 674.9858 m
327.2882 674.9858 l
h
f*
490.0535 649.0205 m
494.8157 649.0205 l
h
f*
499.9748 649.0205 m
509.4992 649.0205 l
h
f*
559.4457 596.9764 m
568.9701 596.9764 l
h
f*
424.2898 571.011 m
433.8142 571.011 l
h
f*
535.9748 544.989 m
545.4992 544.989 l
h
f*
549.9213 544.989 m
559.4457 544.989 l
h
f*
200.0126 532.0063 m
209.537 532.0063 l
h
f*
483.5339 505.9843 m
503.0929 505.9843 l
h
f*
394.8661 414.9921 m
414.4252 414.9921 l
h
f*
423.4961 414.9921 m
433.0205 414.9921 l
h
f*
437.4992 414.9921 m
446.9669 414.9921 l
h
f*
452.1827 414.9921 m
461.6504 414.9921 l
h
f*
244.2898 375.9874 m
253.7575 375.9874 l
h
f*
221.8394 311.0173 m
231.3638 311.0173 l
h
f*
236.5228 311.0173 m
246.0472 311.0173 l
h
f*
474.6898 272.0126 m
484.2142 272.0126 l
h
f*
488.6929 272.0126 m
498.1606 272.0126 l
h
f*
313.285 194.0031 m
322.8094 194.0031 l
h
f*
280.6299 90.0283 m
290.1543 90.0283 l
h
f*
294.6331 90.0283 m
304.1008 90.0283 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Therapeutic)Tj
5.0456 0 Td
(drug)Tj
2.109 0 Td
(monitoring)Tj
4.8188 0 Td
(\(TDM\))Tj
3.1408 0 Td
(is)Tj
0.8504 0 Td
(routinely)Tj
3.8664 0 Td
(used)Tj
2.0579 0 Td
(to)Tj
1.0262 0 Td
(optimize)Tj
3.7304 0 Td
(tacrolimus)Tj
4.4787 0 Td
(\(TAC\))Tj
2.8573 0 Td
(dosing)Tj
-33.9815 -1.3039 Td
(after)Tj
2.0352 0 Td
(organ)Tj
2.5455 0 Td
(transplantation.[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(])Tj
8.708 0 Td
(Traditionally,)Tj
5.6579 0 Td
(the)Tj
1.4683 0 Td
(TAC)Tj
2.177 0 Td
(dose)Tj
2.041 0 Td
(is)Tj
0.8504 0 Td
(adjusted)Tj
3.5716 0 Td
(based)Tj
2.4774 0 Td
(on)Tj
1.2756 0 Td
(whole)Tj
-32.8079 -1.2982 Td
(blood)Tj
2.5114 0 Td
(pre-dose)Tj
3.7021 0 Td
(concentrations)Tj
6.1794 0 Td
(\(C)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 333.9779 661.4362 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(0)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 337.5496 663.0803 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\),)Tj
0.788 0 Td
(that)Tj
1.7745 0 Td
(have)Tj
2.0636 0 Td
(an)Tj
1.2018 0 Td
(imperfect)Tj
4.0536 0 Td
(relationship)Tj
4.9889 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(occurrence)Tj
4.6658 0 Td
(of)Tj
-36.7537 -1.2982 Td
(acute)Tj
2.3244 0 Td
(rejection)Tj
3.7417 0 Td
(and)Tj
1.7292 0 Td
(adverse)Tj
3.2144 0 Td
(events,)Tj
2.9593 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(nephrotoxicity)Tj
6.0945 0 Td
(and)Tj
1.7291 0 Td
(infection.[)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(])Tj
6.6444 0 Td
(A)Tj
0.9014 0 Td
(promising)Tj
-32.4111 -1.3039 Td
(strategy)Tj
3.3279 0 Td
(to)Tj
1.0205 0 Td
(overcome)Tj
4.1499 0 Td
(the)Tj
1.474 0 Td
(limitations)Tj
4.5296 0 Td
(of)Tj
1.0148 0 Td
(traditional)Tj
4.422 0 Td
(pharmacokinetic)Tj
6.9789 0 Td
(TDM)Tj
2.4604 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(to)Tj
1.0262 0 Td
(measure)Tj
-33.4826 -1.2983 Td
(the)Tj
1.4684 0 Td
(biological)Tj
4.0875 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(immunosuppressive)Tj
8.294 0 Td
(drugs)Tj
2.4775 0 Td
(\(pharmacodynamics\).)Tj
-18.8729 -1.2983 Td
(The)Tj
1.7859 0 Td
(primary)Tj
3.4525 0 Td
(biological)Tj
4.0932 0 Td
(target)Tj
2.5115 0 Td
(of)Tj
1.0147 0 Td
(TAC)Tj
2.177 0 Td
(in)Tj
1.0375 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.9219 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(calcineurin)Tj
4.6998 0 Td
(pathway,)Tj
3.7984 0 Td
(of)Tj
1.0148 0 Td
(which)Tj
2.6476 0 Td
(the)Tj
-34.4974 -1.3039 Td
(nuclear)Tj
3.1918 0 Td
(factor)Tj
2.5455 0 Td
(of)Tj
1.0148 0 Td
(activated)Tj
3.7814 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.9219 0 Td
(\(NFAT\))Tj
3.4581 0 Td
(is)Tj
0.8504 0 Td
(one)Tj
1.6951 0 Td
(of)Tj
1.0205 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
2.2054 0 Td
(important)Tj
4.2803 0 Td
(signaling)Tj
3.8211 0 Td
(proteins.[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(])Tj
-32.0823 -1.2982 Td
(The)Tj
1.7802 0 Td
(NFAT)Tj
2.7779 0 Td
(family)Tj
2.7326 0 Td
(consists)Tj
3.3449 0 Td
(of)Tj
1.0148 0 Td
(5)Tj
0.6973 0 Td
(members:)Tj
4.1724 0 Td
(NFATc1)Tj
3.6794 0 Td
(\(NFAT-2\),)Tj
4.5071 0 Td
(NFATc2)Tj
3.6793 0 Td
(\(NFAT-1\),)Tj
4.5127 0 Td
(NFATc3)Tj
-32.8986 -1.2983 Td
(\(NFAT-4\),)Tj
4.5071 0 Td
(NFATc4)Tj
3.6793 0 Td
(\(NFAT-3\))Tj
4.286 0 Td
(and)Tj
1.729 0 Td
(TonEBP)Tj
3.6 0 Td
(\(NFAT-5\).[)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(])Tj
6.1398 0 Td
(NFAT)Tj
2.7779 0 Td
(molecules)Tj
4.201 0 Td
(are)Tj
1.4456 0 Td
(key)Tj
1.5987 0 Td
(players)Tj
-33.9644 -1.2983 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(immune)Tj
3.6227 0 Td
(response)Tj
3.736 0 Td
(after)Tj
2.0353 0 Td
(transplantation)Tj
6.3325 0 Td
(and)Tj
1.7291 0 Td
(are)Tj
1.4513 0 Td
(involved)Tj
3.6453 0 Td
(in)Tj
1.0375 0 Td
(T)Tj
0.8334 0 Td
(cell)Tj
1.559 0 Td
(development,)Tj
5.6353 0 Td
(activa-)Tj
-34.1232 -1.3039 Td
(tion,)Tj
2.0636 0 Td
(differentiation,)Tj
6.2022 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8255 0 Td
(as)Tj
1.0148 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4682 0 Td
(production)Tj
4.7169 0 Td
(of)Tj
1.0148 0 Td
(cytokines)Tj
4.0025 0 Td
(like)Tj
1.6497 0 Td
(interleukin)Tj
4.6431 0 Td
(\(IL\)-2.[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
4.3427 0 Td
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
-34.9906 -1.2983 Td
(14)Tj
0 g
(])Tj
1.1962 -1.2982 Td
(Activation)Tj
4.4051 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(NFAT)Tj
2.7836 0 Td
(family)Tj
2.7269 0 Td
(member)Tj
3.5829 0 Td
(NFATc1)Tj
3.6793 0 Td
(is)Tj
0.8504 0 Td
(initiated)Tj
3.549 0 Td
(when)Tj
2.4037 0 Td
(both)Tj
2.0636 0 Td
(the)Tj
1.4684 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.559 0 Td
(receptor)Tj
-33.5789 -1.3039 Td
(\(TCR\))Tj
2.795 0 Td
(and)Tj
1.7291 0 Td
(co-stimulatory)Tj
6.0888 0 Td
(molecules,)Tj
4.4219 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(CD28,)Tj
2.8007 0 Td
(become)Tj
3.3221 0 Td
(activated)Tj
3.7814 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1)Tj
0 g
(\).)Tj
1.2585 0 Td
(Upon)Tj
2.5285 0 Td
(activa-)Tj
-33.6186 -1.2983 Td
(tion,)Tj
2.0636 0 Td
(the)Tj
1.4684 0 Td
(phosphatase)Tj
5.1307 0 Td
(calcineurin)Tj
4.6998 0 Td
(is)Tj
0.8503 0 Td
(triggered,)Tj
4.0591 0 Td
(which)Tj
2.6476 0 Td
(then)Tj
2.0182 0 Td
(dephosphorylates)Tj
7.2283 0 Td
(NFATc1.)Tj
3.9005 0 Td
(In)Tj
1.1112 0 Td
(turn,)Tj
-35.1777 -1.2983 Td
(dephosphorylated)Tj
7.3927 0 Td
(NFATc1)Tj
3.6737 0 Td
(is)Tj
0.8504 0 Td
(translocated)Tj
5.0909 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(nucleus)Tj
3.2769 0 Td
(where)Tj
2.6475 0 Td
(it)Tj
0.788 0 Td
(interacts)Tj
3.6454 0 Td
(with)Tj
1.9956 0 Td
(other)Tj
2.347 0 Td
(tran-)Tj
-34.2082 -1.3039 Td
(scription)Tj
3.7814 0 Td
(factors,)Tj
3.1295 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(AP-1,)Tj
2.5115 0 Td
(and)Tj
1.7347 0 Td
(induces)Tj
3.2995 0 Td
(gene)Tj
2.0806 0 Td
(transcription.)Tj
-18.4137 -1.2982 Td
(In)Tj
1.1112 0 Td
(contrast)Tj
3.4639 0 Td
(to)Tj
1.0262 0 Td
(other)Tj
2.347 0 Td
(members)Tj
3.9458 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(NFAT)Tj
2.7779 0 Td
(family)Tj
2.7326 0 Td
(that)Tj
1.7745 0 Td
(are)Tj
1.4513 0 Td
(mainly)Tj
2.9877 0 Td
(known)Tj
3.0047 0 Td
(for)Tj
1.389 0 Td
(their)Tj
2.1089 0 Td
(role)Tj
1.7632 0 Td
(in)Tj
-35.5632 -1.2983 Td
(cytokine)Tj
3.6397 0 Td
(production,)Tj
4.9379 0 Td
(NFATc1)Tj
3.6794 0 Td
(is)Tj
0.8504 0 Td
(also)Tj
1.763 0 Td
(known)Tj
3.0047 0 Td
(for)Tj
1.389 0 Td
(its)Tj
1.1452 0 Td
(strongly)Tj
3.4752 0 Td
(inducible)Tj
3.9572 0 Td
(isoform)Tj
3.3391 0 Td
(NFATc1/A.)Tj
-31.1808 -1.2983 Td
(NFATc1/A)Tj
4.6885 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(only)Tj
1.9786 0 Td
(NFAT)Tj
2.7779 0 Td
(member)Tj
3.5829 0 Td
(that)Tj
1.7802 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1509 0 Td
(enhanced)Tj
4.0762 0 Td
(upon)Tj
2.3187 0 Td
(antigenic)Tj
3.9005 0 Td
(stimulation)Tj
4.7905 0 Td
(and)Tj
-34.9906 -1.3039 Td
(maintained)Tj
4.7849 0 Td
(by)Tj
1.1849 0 Td
(positive)Tj
3.3165 0 Td
(autoregulation)Tj
6.0716 0 Td
(in)Tj
1.0375 0 Td
(T)Tj
0.8334 0 Td
(cells)Tj
1.9219 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1)Tj
0 g
(\).[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
2.7779 0 Td
(15)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(])Tj
2.9764 0 Td
(The)Tj
1.7858 0 Td
(calcineurin)Tj
4.6998 0 Td
(inhibitor)Tj
-33.2104 -1.2983 Td
(\(CNI\))Tj
2.6362 0 Td
(cyclosporine)Tj
5.2724 0 Td
(A)Tj
0.9071 0 Td
(is)Tj
0.8447 0 Td
(known)Tj
3.0048 0 Td
(to)Tj
1.0261 0 Td
(inhibit)Tj
2.9025 0 Td
(both)Tj
2.058 0 Td
(the)Tj
1.474 0 Td
(dephosphorylation)Tj
7.7612 0 Td
(of)Tj
1.0148 0 Td
(NFATc1)Tj
3.6793 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
-34.3103 -1.2982 Td
(upregulation)Tj
5.3518 0 Td
(of)Tj
1.0148 0 Td
(NFATc1/A,)Tj
4.9209 0 Td
(but)Tj
1.5534 0 Td
(the)Tj
1.4682 0 Td
(effect)Tj
2.3641 0 Td
(of)Tj
1.0148 0 Td
(tacrolimus)Tj
4.4731 0 Td
(on)Tj
1.2755 0 Td
(NFATc1/A)Tj
4.6942 0 Td
(amplification)Tj
5.5388 0 Td
(is)Tj
0.8448 0 Td
(still)Tj
-34.5144 -1.3039 Td
(unknown.[)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(])Tj
1.1962 -1.2983 Td
(At)Tj
1.2076 0 Td
(present,)Tj
3.3845 0 Td
(clinically)Tj
3.7814 0 Td
(applicable)Tj
4.2349 0 Td
(pharmacodynamic)Tj
7.7272 0 Td
(assays)Tj
2.6248 0 Td
(to)Tj
1.0262 0 Td
(monitor)Tj
3.5376 0 Td
(the)Tj
1.474 0 Td
(biological)Tj
4.0875 0 Td
(effect)Tj
2.3641 0 Td
(of)Tj
-36.646 -1.2983 Td
(TAC)Tj
2.177 0 Td
(are)Tj
1.4514 0 Td
(in)Tj
1.0318 0 Td
(development,)Tj
5.6352 0 Td
(of)Tj
1.0148 0 Td
(which)Tj
2.6531 0 Td
(the)Tj
1.4683 0 Td
(NFAT-regulated)Tj
6.8485 0 Td
(IL-2)Tj
1.9219 0 Td
(gene)Tj
2.0806 0 Td
(expression)Tj
4.4674 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
-33.0687 -1.3039 Td
(promising.)Tj
4.5695 0 Td
(It)Tj
0.856 0 Td
(was)Tj
1.7008 0 Td
(recognized)Tj
4.5921 0 Td
(that)Tj
1.7745 0 Td
(measuring)Tj
4.4389 0 Td
(NFAT-regulated)Tj
6.8485 0 Td
(genes)Tj
2.4434 0 Td
(might)Tj
2.5965 0 Td
(be)Tj
1.1509 0 Td
(a)Tj
0.6519 0 Td
(good)Tj
2.2281 0 Td
(method)Tj
-33.8511 -1.2983 Td
(to)Tj
1.0262 0 Td
(assess)Tj
2.5171 0 Td
(the)Tj
1.474 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(opportunistic)Tj
5.6353 0 Td
(infections,)Tj
4.3765 0 Td
(malignancy)Tj
4.8586 0 Td
(and)Tj
1.7291 0 Td
(acute)Tj
2.3301 0 Td
(rejection)Tj
3.7417 0 Td
(after)Tj
2.0353 0 Td
(transplanta-)Tj
-32.4508 -1.2982 Td
(tion.[)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(])Tj
5.1647 0 Td
(However,)Tj
4.0762 0 Td
(NFAT-regulated)Tj
6.8484 0 Td
(genes,)Tj
2.6645 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(IL-2,)Tj
2.1487 0 Td
(IFN-)Tj
/F11 1 Tf
(\r)Tj
/F7 1 Tf
2.6305 0 Td
(and)Tj
1.7291 0 Td
(GM-CSF)Tj
3.8438 0 Td
(are)Tj
1.4513 0 Td
(activated)Tj
-33.6356 -1.3039 Td
(downstream)Tj
5.1931 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(calcineurin)Tj
4.6998 0 Td
(pathway.)Tj
3.7983 0 Td
(Subsequently,)Tj
5.743 0 Td
(the)Tj
1.474 0 Td
(activation)Tj
4.1499 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2563 0 Td
(genes)Tj
2.4378 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
-34.8999 -1.2983 Td
(influenced)Tj
4.4447 0 Td
(by)Tj
1.1792 0 Td
(other)Tj
2.3471 0 Td
(immunosuppressive)Tj
8.294 0 Td
(drugs,)Tj
2.6986 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(glucocorticoids,)Tj
6.565 0 Td
(and)Tj
1.7348 0 Td
(influenced)Tj
4.4447 0 Td
(by)Tj
-34.7865 -1.2983 Td
(other)Tj
2.3471 0 Td
(signaling)Tj
3.8211 0 Td
(pathways,)Tj
4.1556 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4682 0 Td
(JAK-STAT)Tj
4.6374 0 Td
(signaling)Tj
3.8268 0 Td
(pathway.)Tj
3.7927 0 Td
([)Tj
0.83 0.64 0.02 0 k
(25)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(26)Tj
0 g
(])Tj
1.508 0 Td
(Moreover,)Tj
4.3993 0 Td
(the)Tj
-34.7751 -1.2982 Td
(measuring)Tj
4.4391 0 Td
(of)Tj
1.0148 0 Td
(NFAT-regulated)Tj
6.8428 0 Td
(gene)Tj
2.0805 0 Td
(expression)Tj
4.4673 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(non-validated)Tj
5.7883 0 Td
(tool)Tj
1.7802 0 Td
(to)Tj
1.0204 0 Td
(monitor)Tj
3.5433 0 Td
(the)Tj
1.4683 0 Td
(immu-)Tj
-33.9474 -1.3039 Td
(nosuppressive)Tj
5.862 0 Td
(effects)Tj
2.7213 0 Td
(in)Tj
1.0375 0 Td
(TAC-treated)Tj
5.3063 0 Td
(patients.)Tj
3.5943 0 Td
(A)Tj
0.9014 0 Td
(better)Tj
2.5455 0 Td
(way)Tj
1.7915 0 Td
(for)Tj
1.3833 0 Td
(monitoring)Tj
4.8245 0 Td
(the)Tj
1.4684 0 Td
(direct)Tj
2.5284 0 Td
(biologi-)Tj
-33.9644 -1.2983 Td
(cal)Tj
1.321 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(tacrolimus)Tj
4.4787 0 Td
(might)Tj
2.5965 0 Td
(be)Tj
1.1509 0 Td
(the)Tj
1.4682 0 Td
(measurement)Tj
5.6693 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(immunosuppressive)Tj
8.2998 0 Td
(effect)Tj
2.3641 0 Td
(on)Tj
-33.5733 -1.2983 Td
(NFATc1)Tj
3.6794 0 Td
(amplification.)Tj
5.7599 0 Td
(Flow)Tj
2.1884 0 Td
(cytometry)Tj
4.2688 0 Td
(offers)Tj
2.4605 0 Td
(the)Tj
1.4683 0 Td
(opportunity)Tj
5.0343 0 Td
(to)Tj
1.0262 0 Td
(quantify)Tj
3.5432 0 Td
(the)Tj
1.4684 0 Td
(amplification)Tj
5.5388 0 Td
(of)Tj
-36.4362 -1.3039 Td
(NFATc1/A)Tj
4.6885 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4741 0 Td
(single)Tj
2.5284 0 Td
(cell)Tj
1.5591 0 Td
(level)Tj
2.0182 0 Td
(with)Tj
1.9955 0 Td
(a)Tj
0.652 0 Td
(short)Tj
2.2847 0 Td
(turnaround)Tj
4.8869 0 Td
(time)Tj
2.0239 0 Td
(when)Tj
2.4038 0 Td
(blood)Tj
2.5171 0 Td
(samples)Tj
3.3846 0 Td
(were)Tj
-33.3692 -1.2983 Td
(spiked)Tj
2.812 0 Td
(with)Tj
1.9956 0 Td
(cyclosporine)Tj
5.2724 0 Td
(A.[)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(])Tj
2.7609 0 Td
(This)Tj
1.9841 0 Td
(technique)Tj
4.1669 0 Td
(enables)Tj
3.1635 0 Td
(the)Tj
1.474 0 Td
(measurement)Tj
5.6692 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(immunosup-)Tj
-31.7818 -1.2982 Td
(pressive)Tj
3.3959 0 Td
(drug)Tj
2.1147 0 Td
(effects)Tj
2.7269 0 Td
(on)Tj
1.2755 0 Td
(the)Tj
1.4684 0 Td
(calcineurin)Tj
4.6997 0 Td
(pathway)Tj
3.5716 0 Td
(directly)Tj
3.2315 0 Td
(rather)Tj
2.6475 0 Td
(than)Tj
2.0296 0 Td
(measuring)Tj
4.4391 0 Td
(the)Tj
1.4683 0 Td
(end-prod-)Tj
-33.0687 -1.3039 Td
(ucts)Tj
1.8312 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(pathway,)Tj
3.7928 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(IL-2.)Tj
2.1486 0 Td
(Here,)Tj
2.432 0 Td
(the)Tj
1.4684 0 Td
(applicability)Tj
5.1023 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(NFATc1)Tj
3.6794 0 Td
(amplification)Tj
5.5388 0 Td
(assay)Tj
2.2621 0 Td
(is)Tj
-36.5043 -1.2983 Td
(tested)Tj
2.5512 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8028 0 Td
(time)Tj
2.0296 0 Td
(in)Tj
1.0375 0 Td
(whole-blood)Tj
5.2496 0 Td
(samples)Tj
3.3846 0 Td
(of)Tj
1.0148 0 Td
(TAC-treated)Tj
5.3064 0 Td
(kidney)Tj
2.9367 0 Td
(transplant)Tj
4.2803 0 Td
(recipients)Tj
-32.4508 -1.2983 Td
(and)Tj
1.7292 0 Td
(we)Tj
1.3266 0 Td
(explored)Tj
3.702 0 Td
(whether)Tj
3.4752 0 Td
(this)Tj
1.6781 0 Td
(method)Tj
3.3221 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1509 0 Td
(translated)Tj
4.1612 0 Td
(to)Tj
1.0261 0 Td
(daily)Tj
2.1487 0 Td
(clinical)Tj
3.0784 0 Td
(practice)Tj
3.3789 0 Td
(and)Tj
1.7291 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1451 0 Td
(an)Tj
-36.3058 -1.3039 Td
(additional)Tj
4.2747 0 Td
(tool)Tj
1.7801 0 Td
(for)Tj
1.389 0 Td
(monitoring)Tj
4.8188 0 Td
(the)Tj
1.4684 0 Td
(effects)Tj
2.7268 0 Td
(of)Tj
1.0148 0 Td
(TAC)Tj
2.177 0 Td
(in)Tj
1.0374 0 Td
(different)Tj
3.6567 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.5591 0 Td
(subsets.)Tj
3.2881 0 Td
(Kidney)Tj
3.1125 0 Td
(transplant)Tj
-33.1311 -1.2983 Td
(recipients,)Tj
4.3427 0 Td
(receiving)Tj
3.8664 0 Td
(a)Tj
0.652 0 Td
(belatacept)Tj
4.2292 0 Td
(\(BELA\)-based)Tj
5.8733 0 Td
(maintenance)Tj
5.3915 0 Td
(therapy,)Tj
3.4695 0 Td
(served)Tj
2.7836 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(CNI-free)Tj
-32.275 -1.2982 Td
(control)Tj
3.1181 0 Td
(group,)Tj
2.8347 0 Td
(since)Tj
2.245 0 Td
(BELA)Tj
2.5908 0 Td
(cannot)Tj
2.982 0 Td
(directly)Tj
3.2314 0 Td
(inhibit)Tj
2.9027 0 Td
(the)Tj
1.4683 0 Td
(calcineurin/NFAT)Tj
7.5912 0 Td
(and)Tj
1.7291 0 Td
(other)Tj
2.3471 0 Td
(signaling)Tj
-33.0404 -1.2983 Td
(pathways)Tj
3.9288 0 Td
(in)Tj
1.0375 0 Td
(T)Tj
0.8277 0 Td
(cells.[)Tj
0.83 0.64 0.02 0 k
(27)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
3.668 0 Td
(28)Tj
0 g
(])Tj
1.508 0 Td
(In)Tj
1.1112 0 Td
(addition,)Tj
3.821 0 Td
(NFATc1)Tj
3.6793 0 Td
(amplification)Tj
5.5389 0 Td
(was)Tj
1.6951 0 Td
(also)Tj
1.7688 0 Td
(measured)Tj
4.1102 0 Td
(in)Tj
1.0318 0 Td
(different)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 423.2692 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Effect)Tj
2.7425 0 Td
(of)Tj
1.0417 0 Td
(tacrolimus)Tj
4.6985 0 Td
(on)Tj
1.311 0 Td
(NFATc1)Tj
3.841 0 Td
(amplificatio)Tj
4.904 0 Td
(n)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.02011)Tj
4.089 0 Td
(13)Tj
0 g
2.0906 0 Td
(July)Tj
1.9701 0 Td
(23,)Tj
1.5874 0 Td
(2018)Tj
35.3483 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(15)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(I)Tj
0.4748 0 Td
(have)Tj
1.956 0 Td
(read)Tj
1.8425 0 Td
(the)Tj
1.3677 0 Td
(journal's)Tj
-13.8331 -1.3748 Td
(policy)Tj
2.3952 0 Td
(and)Tj
1.5875 0 Td
(the)Tj
1.3748 0 Td
(authors)Tj
3.0402 0 Td
(of)Tj
0.9496 0 Td
(this)Tj
1.5661 0 Td
(manuscript)Tj
4.415 0 Td
(have)Tj
1.9559 0 Td
(the)Tj
-17.2843 -1.3749 Td
(following)Tj
3.5858 0 Td
(competing)Tj
4.1599 0 Td
(interests:)Tj
3.6142 0 Td
(D.A.)Tj
1.7858 0 Td
(Hesselink)Tj
3.7701 0 Td
(has)Tj
-16.9158 -1.3748 Td
(received)Tj
3.3023 0 Td
(grant)Tj
2.1473 0 Td
(support)Tj
3.0969 0 Td
(from)Tj
2.0126 0 Td
(Bristol-Myer)Tj
4.578 0 Td
(s)Tj
0.6449 0 Td
(Squibb)Tj
-15.782 -1.3748 Td
(and)Tj
1.5874 0 Td
(Astellas)Tj
3.0756 0 Td
(Pharma,)Tj
3.3449 0 Td
(and)Tj
1.5874 0 Td
(lecture)Tj
2.7142 0 Td
(fees)Tj
1.7433 0 Td
(and)Tj
1.5874 0 Td
(grant)Tj
-15.6402 -1.3748 Td
(support)Tj
3.0968 0 Td
(from)Tj
2.0126 0 Td
(Astellas)Tj
3.0686 0 Td
(Pharma)Tj
3.1252 0 Td
(and)Tj
1.5874 0 Td
(Chiesi)Tj
-12.8906 -1.3748 Td
(Pharmaceu)Tj
4.2165 0 Td
(ticals.)Tj
2.3528 0 Td
(C.C.)Tj
1.7221 0 Td
(Baan)Tj
2.0551 0 Td
(received)Tj
3.3024 0 Td
(a)Tj
0.6449 0 Td
(research)Tj
-14.2938 -1.3748 Td
(grant)Tj
2.1543 0 Td
(from)Tj
2.0055 0 Td
(Bristol-Myer)Tj
4.578 0 Td
(s)Tj
0.6449 0 Td
(Squibb.)Tj
3.0544 0 Td
(This)Tj
1.7858 0 Td
(does)Tj
2.0055 0 Td
(not)Tj
-16.2284 -1.3748 Td
(alter)Tj
1.8212 0 Td
(our)Tj
1.4741 0 Td
(adherenc)Tj
3.4086 0 Td
(e)Tj
0.6449 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3316 0 Td
(ONE)Tj
1.8637 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
-15.5056 -1.3748 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.793 0 Td
(and)Tj
ET
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
BT
6.3638 71.7171 Td
(materials.)Tj
ET
Q
endstream
endobj
59 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 63 0 R/Contents 64 0 R/TrimBox[0 0 612 792]>>
endobj
62 0 obj
<>stream
x|{B
]"wB
*(( (PA"{H/;K,=wͲI6aɇ{v̙<_ {II-" H %9(=on@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ HIIٲe˸qF9jԨ~{ɲ=kn*_
3gŋS;dS!C|GI]2eǏxb90kYnPnj2ǧM6lذwyG;w7ݻoݻwN$bqqq7o[ᅲg-Omر;vޟ p~UZXbݗsʕ###E7|SB3
4XnhҤO<㏗*U78x駟ZmOǗ/S~ zY(.Ydhh۷8l4ԬFT?>lA @ @ @ @ @ % ...u
OOO)QF-7X`ɓ'ҥKm$hŊhݴ"}ԩ-&|Y9Dv(P@Jܹcrh7((h۶m&ҢM=d?nlD @ @ @ @ @ o{1L